CB
AGN

Cooke & Bieler’s Allergan plc AGN Stock Holding History

Cooke & Bieler’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-214,190
Closed -$40.9M – 102
2019
Q4 		$40.9M Sell
214,190
-208,330
-49% -$37.6M 0.44% 75
2019
Q3 		$71.1M Sell
422,520
-315,538
-43% -$51.4M 1.21% 39
2019
Q2 		$124M Buy
738,058
+52,641
+8% +$7.29M 2.16% 7
2019
Q1 		$100M Sell
685,417
-340
-0% -$49.3K 1.81% 17
2018
Q4 		$91.7M Sell
685,757
-63,334
-8% -$10.4M 1.86% 15
2018
Q3 		$143M Buy
749,091
+8,275
+1% +$1.52M 2.43% 6
2018
Q2 		$124M Sell
740,816
-41,094
-5% -$6.6M 2.22% 7
2018
Q1 		$132M Buy
781,910
+100,085
+15% +$16.8M 2.46% 2
2017
Q4 		$112M Buy
681,825
+238,233
+54% +$42.8M 2.02% 10
2017
Q3 		$90.9M Buy
443,592
+38,391
+9% +$8.93M 1.69% 22
2017
Q2 		$98.5M Buy
405,201
+81,070
+25% +$19.1M 1.89% 18
2017
Q1 		$77.4M Sell
324,131
-6,972
-2% -$1.62M 1.51% 27
2016
Q4 		$69.5M Buy
+331,103
New +$68.6M 1.38% 35

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cooke & Bieler's AGN Position: Q1 2020 in Review

Cooke & Bieler sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 214,190 shares — an estimated $40.9M sold.

Cooke & Bieler first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $143M in Q3 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Cooke & Bieler reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Cooke & Bieler sold 214,190 Allergan plc shares in Q1 2020, an estimated $40.9M.
  • Cooke & Bieler first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
  • Cooke & Bieler's Allergan plc position peaked at $143M in Q3 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Cooke & Bieler's 13F filing for Q1 2020, filed 6 May 2020.